5‑HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines

Psychedelic compounds have displayed antidepressant potential in both humans and rodents. Despite their promise, psychedelics can induce undesired effects that pose safety concerns and limit their clinical scalability. The rational development of optimized psychedelic-related medicines will require...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	ACS chemical neuroscience 2023-02, Vol.14 (3), p.351-358
Hauptverfasser:	Cameron, Lindsay P., Patel, Seona D., Vargas, Maxemiliano V., Barragan, Eden V., Saeger, Hannah N., Warren, Hunter T., Chow, Winston L., Gray, John A., Olson, David E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Hallucinogens - pharmacology Hallucinogens - therapeutic use Humans Rodentia Tryptamines - pharmacology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!